Abingdon Health Ltd, is pleased to announce the appointment of Michael Hunter as Operations Director, effective 1 November 2015.
Michael will be responsible for Abingdon Health’s ISO 13485 certified lateral flow manufacturing activities based at the Group’s York site. These activities comprise the manufacture of the group’s proprietary rapid testing products in the area of hematology-oncology as well as a growing number of contract manufacturing partnerships. Michael will be a member of the Group’s Executive Team and will report into Chris Yates, CEO.
Michael has over 20 years’ experiences in operational roles in the healthcare industry at Bristol-Myers Squibb, SSL International, Leica Biosystems (Danaher) and Immunodiagnostic Systems. Michael’s experience includes implementation of lean manufacturing, manufacturing under a GMP compliant Quality systems and ERP implementation.
“I’m pleased to be joining the organisation at such an exciting time as we look to enhance our manufacturing capabilities to support the expansion of our range of proprietary products and lateral flow contract services customers’ products.“